After a median follow-up of 13.3 months (95% CI, 9.04-18.69), the median duration of response was 18.1 months, progression ...

Dr. Lakshmi Nayak, director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute, explained in an interview with ...

Children of Hispanic ethnicity have a higher risk of developing neurotoxicity when they are treated with methotrexate for acute lymphoblastic leukemia (ALL) compared with non-Hispanic white children.

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, ...

New research has uncovered the previously unknown presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple ...

Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer: First Human Application and Potential Antitumor Mechanisms Neurotoxicity is becoming increasingly ...

Over the last decades, improvement in early diagnosis, precise subtype characterization, and more effective treatment plans allowed clinicians to achieve complete cures or remarkable increases in long ...

Please provide your email address to receive an email when new articles are posted on . Researchers have discovered a link between neurotoxicity related to chimeric antigen receptor T-cell therapy and ...

In the human brain, synaptogenesis commences in the last trimester of pregnancy and is complete by the end of the third to fourth year of life. Lasting changes may theoretically occur when this ...